Sagent Pharmaceutical’s Sequential Syringes

Sagent Pharmaceuticals of Schaumburg, IL, has acquired a multi-chamber sequential syringe delivery system from Infusive Technologies, a Utah company, which allows for multiple drug solution deliveries through one (conventional) syringe. Jeffrey M. Yordon, chairman, founder and chief executive officer of Sagent Pharmaceuticals notes that a single syringe push allows for the delivery of separate IV medications. This not only increases the speed of medication delivery but reduces the number of IV connections required (thus lowering the incidence of nosocomial infections), as well as reducing medication delivery errors.

Infusive’s Chief Executive Officer, Bradley C. Robinson said “Syringes based on our unique, patented technologies have the potential to dramatically improve the delivery of IV medications, reduce the risk of medical error and hospital-acquired infection while at the same time lowering costs for healthcare providers. Infusive remains committed to providing quality IV medication delivery systems that enhance effectiveness and improve patient safety.” Robinson says “I look forward to joining Jeff and the team at Sagent and to quickly make this exciting new device available to patients and caregivers.”
The unique dual-chamber syringe can accommodate lyophilized (dried by freezing in a high vacuum), powder or liquid formulations in the front chamber combined with diluents, saline or heparin flush in the rear chamber.
More information about ChaSyr™ syringes can be found on Infusive website…
Press release: Sagent Pharmaceuticals acquires rights to multi-chamber syringe technology and launches device division…
Sagent Pharmaceuticals…